For Institutions
About
Lepu Medical's subsidiary, Lepu Medical Electronics, has obtained registration approval from the National Medical Products Administration (NMPA) for its self-developed rechargeable implantable deep brain stimulation system product. This technology regulates neural electrical activity in the brain through implanted electrodes, providing new treatment options for Parkinson's disease patients and marking an important advancement for the company in the field of neuromodulation
Mindray released its Q3 2025 report, with operating revenue for the first three quarters at 25.834 billion yuan, a year-on-year decrease of 12.38%; net profit attributable to the parent company was 7.57 billion yuan, a year-on-year decline of 28.83%; net profit excluding non-recurring gains and losses was 7.463 billion yuan, a year-on-year decrease of 28.50%; basic earnings per share were 6.2481 yuan
Imeik Technology Development Co Ltd :Q3 NET PROFIT DOWN 34.6% Y/Y
Aier Eye Hospital Q3 net profit down 24.1% Y/Y
According to the Zhitong Finance APP, YUYUE MEDICAL released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 6.545 billion yuan, a year-on-year increase of 8.58%. The net profit attributable to shareholders of the listed company was 1.466 billion yuan, a year-on-year decrease of 4.28%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.169 billion yuan, a year-on-year decrease of 8.21%. The basic earnings per share were 1.4687 yuan
